Did you guys miss this or something.
https://cellmid.com.au/wp-content/uploads/2021/01/Appendix-4C-and-Quarterly-Activity-Report.pdf
Anyone saying we are in the dark might want to take a look at it.
Plenty of information in there and all publicly known.
For paired read pared.
How much information specifically do you need?
Daily sales ticker counter in the corner of the webpage?
Summaries once a week from all sales sources separately, audited by PWC and verified at the highest ASX level as true and accurate?
Constant verification that ongoing Lyramid access negotiations for divestment are going smoothly, who is involved, and which part , at what price, if any, and delivered by personal email with separate text backup or failing that urgent courier?
Dont hold your breath
Half Year coming up
- Forums
- ASX - By Stock
- AN1
- Ann: Cellmid Publishes Data on Novel Proprietary FGF5 Aptamer
Ann: Cellmid Publishes Data on Novel Proprietary FGF5 Aptamer, page-19
-
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online